Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

County commissioners last year voted to replace the bridge and remove the nearby Rapidan Dam, both of which were at risk of ...

As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow.1 These patients may now be ...

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY ...

A House committee will hold a hearing this week scrutinizing whether National Institutes of Health animal research amounts to ...

This article summarizes the provisions of the final 2026 HHS Notice of Benefit Payment Parameters related to the individual ...

A Morris County man is suing the Easton Police Department, Northampton County, and others, for their alleged role in his ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

While the new Bell to Bell, No Cell Act awaits House approval, the Lake Hamilton School District is already looking at ways to curb cellphone use in its schools.